Dierich M P, Schulz T, Yefenof E, Klein G
Eur J Immunol. 1979 Dec;9(12):928-32. doi: 10.1002/eji.1830091204.
Mouse mastocytoma cells (P 815) formed rosettes with normal mouse spleen lymphocytes which had been coated with uncleaved human C 3; this interaction was clearly dependent on the amount of C 3. Lymphocytes treated with C 3 b or buffer alone were ineffective. Formation of cell contact could be inhibited by the presence of protease inhibitors such as diisopropyl fluorophosphate, phenyl methyl sulfonyl fluoride and tosyllysyl chloromethyl ketone. Seve n out of 13 different cell lines behaved like P 815 cells. The results strongly suggested that a proteolytic activity on mouse tumor cells led to a cooperation with uncleaved C 3 on a carrier cell to connect these two cells. We interpreted these data in analogy to the complement-dependent bridge formation mechanism (M. P. Dierich and B. Landen, J. Exp. Med. 1977. 146: 1484): uncleaved C 3, attached to mouse spleen lymphocytes as carriers, becomes cleaved by enzymes associated with the tumor cells tested; by this cleavage, the labile binding site is released on C 3 (nascent C 3 b) and anchors the C 3-carrying cell to the protease-carrying cell; since this labile binding site is short-lived, this process can be induced by membrane-associated proteases only. The nature of the proteases and the biological implications of this process are as yet uncertain.
小鼠肥大细胞瘤细胞(P 815)与已包被未裂解人C 3的正常小鼠脾淋巴细胞形成玫瑰花结;这种相互作用明显依赖于C 3的量。单独用C 3 b或缓冲液处理的淋巴细胞无效。细胞接触的形成可被蛋白酶抑制剂如二异丙基氟磷酸酯、苯甲基磺酰氟和甲苯磺酰赖氨酰氯甲酮抑制。13种不同细胞系中有7种表现得与P 815细胞相似。结果强烈表明,小鼠肿瘤细胞上的蛋白水解活性导致与载体细胞上未裂解的C 3协同作用,从而连接这两种细胞。我们根据补体依赖性桥形成机制(M. P. 迪里希和B. 兰登,《实验医学杂志》1977年。146: 1484)来解释这些数据:作为载体附着于小鼠脾淋巴细胞上的未裂解C 3被受试肿瘤细胞相关的酶裂解;通过这种裂解,C 3上不稳定的结合位点被释放(新生C 3 b),并将携带C 3的细胞锚定到携带蛋白酶的细胞上;由于这个不稳定的结合位点寿命短暂,这个过程只能由膜相关蛋白酶诱导。蛋白酶的性质以及这个过程的生物学意义尚不确定。